PT - JOURNAL ARTICLE AU - Karl M. Aspelund AU - Michael Droste AU - James H. Stock AU - Christopher D. Walker TI - Identification and Estimation of Undetected COVID-19 Cases Using Testing Data from Iceland AID - 10.1101/2020.04.06.20055582 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.06.20055582 4099 - http://medrxiv.org/content/early/2020/06/23/2020.04.06.20055582.short 4100 - http://medrxiv.org/content/early/2020/06/23/2020.04.06.20055582.full AB - In the early stages of the COVID-19 pandemic, international testing efforts tended to target individuals whose symptoms and/or jobs placed them at a high presumed risk of infection. Testing regimes of this sort potentially result in a high proportion of cases going undetected. Quantifying this parameter, which we refer to as the undetected rate, is an important contribution to the analysis of the spread of the SARS-CoV-2 virus. We show that partial identification techniques can credibly deal with the data problems that common COVID-19 testing programs induce (i.e. excluding quarantined individuals from testing and low participation in random screening programs). We use public data from two Icelandic testing regimes during the first month of the outbreak and estimate an identified interval for the undetected rate. Our main approach estimates that the undetected rate was between 89% and 93% before the medical system broadened its eligibility criteria and between 80% and 90% after.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe have no external support for this project. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. 1122374.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available. We use counts of tests and confirmed COVID-19 infections from the Icelandic Health Directorate's COVID-19 information website. We also use counts of cases reporting flu-like symptoms from the influenza website of the country's Health Directorate. We use quarantine numbers from the Department of Civil Defense's announcement page. https://www.landlaeknir.is/servlet/file/store93/item32967/influensulik.einkenni.uppfaersla.a.vef.okt2017.AG.xls_%C3%A1n%20myndar%20og%20aldursdreifingu.xls https://www.covid.is/data https://www.almannavarnir.is/utgefid-efni/